BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 405394)

  • 1. Inosine uptake by cultured fibroblasts from normal and purine nucleoside phosphorylase-deficient humans.
    Cohen A; Martin DW
    J Biol Chem; 1977 Jun; 252(12):4428-30. PubMed ID: 405394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine metabolism in intact cells from a purine nucleoside phosphorylase deficient child.
    Cohen A; Barankiewicz J; Issekutz A; Gelfand EW
    Adv Exp Med Biol; 1984; 165 Pt B():163-6. PubMed ID: 6426262
    [No Abstract]   [Full Text] [Related]  

  • 3. Inosine formation from hypoxanthine by intact erythrocytes and fibroblasts of an immunodeficient child with purine nucleoside phosphorylase deficiency.
    Fairbanks LD; Webster DR; Simmonds HA; Potter CF; Watson AR
    Adv Exp Med Biol; 1984; 165 Pt B():167-70. PubMed ID: 6426263
    [No Abstract]   [Full Text] [Related]  

  • 4. Purine metabolism in cultured human fibroblasts derived from patients deficient in hypoxanthine phosphoribosyltransferase, purine nucleoside phosphorylase, or adenosine deaminase.
    Thompson LF; Willis RC; Stoop JW; Seegmiller JE
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3722-6. PubMed ID: 99741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of purine nucleosides in cultured fibroblasts from a patient with purine nucleoside phosphorylase deficiency and associated T-cell immunodeficiency.
    Burke WG; Chen SH; Scott CR; Ammann AJ
    J Cell Physiol; 1977 Jul; 92(1):109-13. PubMed ID: 408357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient with purine nucleoside phosphorylase deficiency: enzymological and metabolic aspects.
    Siegenbeek Van Heukelom LH; Akkerman JW; Staal GE; De Bruyn CH; Stoop JW; Zegers BJ; De Bree PK; Wadman SK
    Clin Chim Acta; 1977 Feb; 74(3):271-9. PubMed ID: 401697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed explanation for S-adenosylhomocysteine hydrolase deficiency in purine nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase-deficient patients.
    Hershfield MS
    J Clin Invest; 1981 Mar; 67(3):696-701. PubMed ID: 6782120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purine nucleoside phosphorylase deficiency: altered kinetic properties of a mutant enzyme.
    Fox IH; Andres CM; Gelfand EW; Biggar D
    Science; 1977 Sep; 197(4308):1084-6. PubMed ID: 407651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.
    Cohen A; Doyle D; Martin DW; Ammann AJ
    N Engl J Med; 1976 Dec; 295(26):1449-54. PubMed ID: 825775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitated transport of inosine and uridine in cultured mammalian cells is independent of nucleoside phosphorylases.
    Plagemann PG; Wohlhueter RM; Erbe J
    Biochim Biophys Acta; 1981 Jan; 640(2):448-62. PubMed ID: 6783140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of adenine, hypoxanthine and uracil into Escherichia coli.
    Burton K
    Biochem J; 1977 Nov; 168(2):195-204. PubMed ID: 413544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered purine and pyrimidine metabolism in erythrocytes with purine nucleoside phosphorylase deficiency.
    Fox IH; Kaminska J; Edwards NL; Gelfand E; Rich KC; Arnold WN
    Biochem Genet; 1980 Apr; 18(3-4):221-34. PubMed ID: 6160848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyguanosine toxicity on lymphoid cells as a cause for immunosuppression in purine nucleoside phosphorylase deficiency.
    Chan TS
    Cell; 1978 Jul; 14(3):523-30. PubMed ID: 99242
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
    Ullman B; Cohen A; Martin DW
    Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for active purine nucleoside cycles in human mononuclear cells and cultured fibroblasts.
    Barankiewicz J; Gelfand EW; Issekutz A; Cohen A
    J Biol Chem; 1982 Oct; 257(19):11597-600. PubMed ID: 6811584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of TEI-6720, a xanthine oxidase inhibitor, on the nucleoside transport in the lung cancer cell line A549.
    Yamamoto T; Moriwaki Y; Fujimura Y; Takahashi S; Tsutsumi Z; Tsutsui T; Higashino K; Hada T
    Pharmacology; 2000 Jan; 60(1):34-40. PubMed ID: 10629441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The existance of a group translocation transport mechanism in animal cells: uptake of the ribose moiety of inosine.
    Quinlan DC; Li CC; Hochstadt J
    J Supramol Struct; 1976; 4(4):387-99. PubMed ID: 180353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hexamere purine nucleoside phosphorylase from Escherichia coli K-12. Kinetic analysis and mechanism of reaction].
    Bezirdzhian KhO; Kocharian ShM; Akopian ZhI
    Biokhimiia; 1987 Nov; 52(11):1770-6. PubMed ID: 3125860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of 5-methyluridine by immobilized thermostable purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase from Bacillus stearothermophilus JTS 859.
    Hori N; Watanabe M; Sunagawa K; Uehara K; Mikami Y
    J Biotechnol; 1991 Feb; 17(2):121-31. PubMed ID: 1367490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.